1982年11月10日出生，2004年本科毕业于蚌埠银河集团186net，2012年南京医科大学硕士毕业后考入东南大学，2014年获国家留学基金委资助，以联合培养博士身份赴耶鲁大学留学，2016年回国，同年6月毕业于东南大学，获医学博士学位。在读期间发表SCI论文4篇，申请江苏省研究生创新基金1项。 主要论文 1. Xiaoying Wang,Xiangfeng He,Fengshu Zhao, et al. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis. Journal of Translational Medicine, 2014. 2. Xiaoying Wang,Xiangfeng He,Fengshu Zhao, et al. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine. Oncotarget, 2015. 3. Xiaoying Wang,Xiangfeng He, Fengshu Zhao, et al. Reinforce of B16F10/GPI-IL-21 vaccine against melanoma efficacy via adminsistration of miR200c agomir and shZEB1 plasmid in mice, Biomedicine & Pharmacotherapy, 2016. 4. Xiaoying Wang,Jiangbing Zhou, et al. Hypouricemic and Nephroprotective Effects of AS1202 in a Rat Model of hyperuricemia. International Journal of Clinical and Experimental Medicine,2016. |
